How often should imaging be performed to follow an asymptomatic splenic artery aneurysm that is less than 2 cm in size?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Imaging Surveillance for Splenic Artery Aneurysms <2 cm

For asymptomatic splenic artery aneurysms less than 2 cm, perform annual imaging surveillance for the first 3 years, then extend intervals to every 2-3 years if the aneurysm remains stable.

Evidence-Based Surveillance Strategy

While no formal guidelines exist specifically for splenic artery aneurysm surveillance (the ESC guidelines 1 address aortic aneurysms only), the most recent and comprehensive research provides clear direction:

Initial 3-Year Period: Annual Surveillance

The 2026 systematic review 2 analyzing 1,774 splenic artery aneurysms demonstrates that these lesions are remarkably indolent, with:

  • Mean growth rate of only 0.04 cm/year
  • 78% remaining completely stable
  • Rupture risk of only 0.2% (4 ruptures total, three occurring in aneurysms <2 cm)

The authors specifically recommend yearly surveillance for 3 years after discovery of asymptomatic SAAs under 2 cm, followed by surveillance at increasing intervals 2. This recommendation is reinforced by their local cohort showing minimal growth (0.05 cm/year) with zero ruptures over 46 months of follow-up.

After 3 Years: Extended Intervals

The 2024 study 3 of 890 splenic artery aneurysms with mean 3.8-year radiological follow-up confirms this conservative approach is safe:

  • Mean diameter at diagnosis: 13.3 mm
  • Growth rates for aneurysms <20 mm: approximately 0.17 mm/year
  • Only 3.2% eventually required intervention over 4 years

The 2011 series 4 further validates this strategy, showing observed aneurysms <2 cm grew at only 0.2 mm/year with no late aneurysm-related mortality over 10-year follow-up.

Imaging Modality Selection

Use duplex ultrasound (DUS) or MRI for routine surveillance to avoid cumulative radiation exposure, particularly in younger patients who may require decades of monitoring 2.

  • MRI/MRA is superior for detecting small changes in aneurysm perfusion and is radiation-free 5
  • CT angiography should be reserved for emergency situations or when other modalities are inadequate
  • Ultrasound can supplement MRI in low-risk patients but should not be used alone

Factors Warranting Closer Surveillance

Monitor more frequently (every 6 months) if:

  • Tobacco use (independently predicts growth) 3
  • Female sex (associated with growth and 4-fold higher rupture risk) 2
  • Portal hypertension (associated with growth) 2
  • Documented growth ≥3 mm over any interval 2
  • Size approaching 2 cm (threshold for intervention consideration)

Critical Caveats

Increasing circumferential calcification is protective and independently predicts reduced growth 2. Heavily calcified aneurysms may warrant less frequent surveillance.

Mural thrombus does NOT predict rupture risk despite historical concerns 2. Do not intensify surveillance based on thrombus presence alone.

Women of childbearing age represent a special population where intervention is often recommended regardless of size due to catastrophic rupture risk during pregnancy, though the 2024 study 3 notes these guidelines are poorly followed in practice (only 5.3% of their cohort were childbearing age, with minimal intervention rates).

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.